Cited by 1,116Immune Response and InflammationSystemic Lupus Erythematosus ResearchT-cell and B-cell Immunology

Toll-like receptors in systemic autoimmune disease

Open access
Marshak-Rothstein, Ann·2006·Nature Reviews Immunology

Abstract

Toll-like receptors (TLRs) have a crucial role in the early detection of pathogen-associated molecular patterns and the subsequent activation of the adaptive immune response. Whether TLRs also have an important role in the recognition of endogenous ligands has been more controversial. Numerous in vitro studies have documented activation of both autoreactive B cells and plasmacytoid dendritic cells by mammalian TLR ligands. The issue of whether these in vitro observations translate to an in vivo role for TLRs in either the initiation or the progression of systemic autoimmune disease is a subject of intense research; data are beginning to emerge showing that this is the case.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nri1957

Cites

129 of 129 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HMGB1 may act on RAGE and possibly on TLR2 and TLR4, although the TLR action is controversial.

    “Thus, HMGB1 may act on the receptor for advanced glycated endproducts (RAGEs) and possibly the toll-like receptors (TLRs) including TLR2 and TLR4 51,52, although the latter are controversial 53.”

    From Immunogenic and tolerogenic cell death (2009) · cites this paper as [53]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Marshak-Rothstein, A.
Venue
Nature Reviews Immunology
Published
2006-11-01
Volume
6
Issue
11
Pages
823-835
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
OpenAlex
W1985477675
Cited by
1,116
References
129
Citations by year
2026: 21 · 2025: 18 · 2024: 41 · 2023: 30 · 2022: 34 · 2021: 39 · 2020: 43 · 2019: 33 · 2018: 51 · 2017: 57 · 2016: 54 · 2015: 68 · 2014: 61 · 2013: 71 · 2012: 71
FWCI
6.33
Type
journal article
Language
en
Open access
Locations
  • Nature reviews. Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • School of Medicine, Boston University
  • National Institutes of Health
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
Toll-like receptors, systemic autoimmune diseases, endogenous ligands, autoreactive B cells, plasmacytoid dendritic cells, pathogen-associated molecular patterns
MeSH terms
Animals, Autoantibodies, Humans, Ligands, Lupus Erythematosus, Systemic, Interferon-alpha, Models, Immunological, Toll-Like Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review